<code id='62BF0B12EA'></code><style id='62BF0B12EA'></style>
    • <acronym id='62BF0B12EA'></acronym>
      <center id='62BF0B12EA'><center id='62BF0B12EA'><tfoot id='62BF0B12EA'></tfoot></center><abbr id='62BF0B12EA'><dir id='62BF0B12EA'><tfoot id='62BF0B12EA'></tfoot><noframes id='62BF0B12EA'>

    • <optgroup id='62BF0B12EA'><strike id='62BF0B12EA'><sup id='62BF0B12EA'></sup></strike><code id='62BF0B12EA'></code></optgroup>
        1. <b id='62BF0B12EA'><label id='62BF0B12EA'><select id='62BF0B12EA'><dt id='62BF0B12EA'><span id='62BF0B12EA'></span></dt></select></label></b><u id='62BF0B12EA'></u>
          <i id='62BF0B12EA'><strike id='62BF0B12EA'><tt id='62BF0B12EA'><pre id='62BF0B12EA'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:5114
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Stem cell treatment guidelines are released by FDA
          Stem cell treatment guidelines are released by FDA

          HumanembryonicstemcellsAnnieCavanagh/WellcomeImagesTheFoodandDrugAdministrationonThursdayunveiledase

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Campaign finance charge dropped from case against Sam Bankman

          FTXfounderSamBankman-FriedleavesFederalcourt,Wednesday,July26,2023,inNewYork.(APPhoto/MaryAltaffer)T